{"transactions":[{"id":723822,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2026-06-29T21:59:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":369,"derivative":{"underlying":"Common Stock","underlying_shares":369},"source":{"system":"sec-edgar","filing":"0001250252-26-000007","document":"wk-form4_1782770364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000007/wk-form4_1782770364.xml","form_type":"4"}},{"id":723821,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2026-06-29T21:59:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":3698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027."}],"balance_after":3698,"derivative":{"underlying":"Common Stock","underlying_shares":3698},"source":{"system":"sec-edgar","filing":"0001250252-26-000007","document":"wk-form4_1782770364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000007/wk-form4_1782770364.xml","form_type":"4"}},{"id":723820,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2026-06-29T21:59:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":15532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."}],"balance_after":15532,"derivative":{"underlying":"Common Stock","underlying_shares":15532},"source":{"system":"sec-edgar","filing":"0001250252-26-000007","document":"wk-form4_1782770364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000007/wk-form4_1782770364.xml","form_type":"4"}},{"id":745983,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-06-08T21:14:27.000Z","date":"2026-06-04","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 30, 2017 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-262067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526262067/ownership.xml","form_type":"4"}},{"id":745982,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-08T21:14:27.000Z","date":"2026-06-04","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":26.27,"value":656750.0,"ownership":{"direct":true},"balance_after":40384,"source":{"system":"sec-edgar","filing":"0001193125-26-262067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526262067/ownership.xml","form_type":"4"}},{"id":754304,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2026-06-02T20:07:43.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 29, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001250252-26-000006","document":"wk-form4_1780430859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000006/wk-form4_1780430859.xml","form_type":"4"}},{"id":754303,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:07:43.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":23257,"source":{"system":"sec-edgar","filing":"0001250252-26-000006","document":"wk-form4_1780430859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000006/wk-form4_1780430859.xml","form_type":"4"}},{"id":761503,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2026-05-27T20:07:23.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":234},"source":{"system":"sec-edgar","filing":"0001250252-26-000004","document":"wk-form4_1779912440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000004/wk-form4_1779912440.xml","form_type":"4"}},{"id":761502,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2026-05-27T20:07:23.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1173},"source":{"system":"sec-edgar","filing":"0001250252-26-000004","document":"wk-form4_1779912440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000004/wk-form4_1779912440.xml","form_type":"4"}},{"id":761501,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T20:07:23.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":16428,"source":{"system":"sec-edgar","filing":"0001250252-26-000004","document":"wk-form4_1779912440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000004/wk-form4_1779912440.xml","form_type":"4"}},{"id":761500,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T20:07:23.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":1173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":16194,"source":{"system":"sec-edgar","filing":"0001250252-26-000004","document":"wk-form4_1779912440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025226000004/wk-form4_1779912440.xml","form_type":"4"}},{"id":929035,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-01-29T01:30:10.000Z","date":"2026-01-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to that certain Arrangement Agreement, dated November 14, 2025 (the \"Arrangement Agreement\"), by and between the Issuer and XenoTherapeutics, Inc. (the \"Parent\"), Xeno Acquisition Corp. (the \"Purchaser\"), and XOMA Royalty Corporation (\"XRC\"), in exchange for (i) $2.20 in cash per share, plus (ii) one non-transferable contingent value right (\"CVR\") per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Arrangement Agreement, the Purchaser acquired all of the issued and outstanding common shares of the Issuer for (i) $2.20 in cash per share plus (ii) one CVR per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250252-26-000002","document":"form4-01282026_080107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000125025226000002/form4-01282026_080107.xml","form_type":"4"}},{"id":932089,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-01-23T21:56:45.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 21, 2026, and will vest on January 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":94.15,"expiration_date":"2036-01-21","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-021218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526021218/ownership.xml","form_type":"4"}},{"id":974255,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T23:37:17.000Z","date":"2025-12-10","kind":"purchase","planned":false,"acquired":true,"shares":750,"price":28.275,"value":21206.25,"ownership":{"direct":true},"balance_after":15021,"source":{"system":"sec-edgar","filing":"0001250252-25-000004","document":"wk-form4_1765409834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000125025225000004/wk-form4_1765409834.xml","form_type":"4"}},{"id":1003553,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-10T21:15:55.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":85,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person."}],"balance_after":15384,"source":{"system":"sec-edgar","filing":"0001193125-25-274288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525274288/ownership.xml","form_type":"4"}},{"id":1003552,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-10T21:15:55.000Z","date":"2025-11-07","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":81,"value":648000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person."}],"balance_after":17384,"source":{"system":"sec-edgar","filing":"0001193125-25-274288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525274288/ownership.xml","form_type":"4"}},{"id":1039149,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-16T21:16:05.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":58.46,"value":584600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $58.22-$58.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":25384,"source":{"system":"sec-edgar","filing":"0001193125-25-205135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525205135/ownership.xml","form_type":"4"}},{"id":1052965,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T16:30:06.000Z","date":"2025-08-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 18, 2025, by and among iTeos Therapeutics, Inc. (the \"Company\"), Concentra Biosciences LLC (\"Parent\"), and Concentra Merger Sub VIII, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Parent completed a tender offer for shares of common stock of the Company (\"Shares\") and thereafter, the Merger Sub merged with and into the Company (the \"Merger\"). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, by virtue of the Merger and without any action on the part of the holders, each option to purchase Shares from the Company (\"Company Stock Options,\" and each such option, a \"Company Stock Option\") that had an exercise price per share that is less than $10.047 in cash per share (the \"Cash Amount\") (each, an \"In-the-Money Option\")"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) that was then outstanding was canceled and, in exchange therefor, the holder of such canceled In-the-Money Option became entitled to receive in consideration of the cancellation of such In-the-Money Option (x) an amount in cash without interest, subject to any applicable tax withholding, equal to the product obtained by multiplying (1) the excess of the Cash Amount over the exercise price per Share underlying such In-the-Money Option by (2) the number of Shares underlying such In-the-Money Option as of immediately prior to the Effective Time and (y) one non-transferable contractual contingent value right for each Share underlying such In-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 18, 2025, by and among iTeos Therapeutics, Inc. (the \"Company\"), Concentra Biosciences LLC (\"Parent\"), and Concentra Merger Sub VIII, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Parent completed a tender offer for shares of common stock of the Company (\"Shares\") and thereafter, the Merger Sub merged with and into the Company (the \"Merger\"). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, by virtue of the Merger and without any action on the part of the holders, each option to purchase Shares from the Company (\"Company Stock Options,\" and each such option, a \"Company Stock Option\") that had an exercise price per share that is less than $10.047 in cash per share (the \"Cash Amount\") (each, an \"In-the-Money Option\")"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) that was then outstanding was canceled and, in exchange therefor, the holder of such canceled In-the-Money Option became entitled to receive in consideration of the cancellation of such In-the-Money Option (x) an amount in cash without interest, subject to any applicable tax withholding, equal to the product obtained by multiplying (1) the excess of the Cash Amount over the exercise price per Share underlying such In-the-Money Option by (2) the number of Shares underlying such In-the-Money Option as of immediately prior to the Effective Time and (y) one non-transferable contractual contingent value right for each Share underlying such In-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 18, 2025, by and among iTeos Therapeutics, Inc. (the \"Company\"), Concentra Biosciences LLC (\"Parent\"), and Concentra Merger Sub VIII, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Parent completed a tender offer for shares of common stock of the Company (\"Shares\") and thereafter, the Merger Sub merged with and into the Company (the \"Merger\"). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, by virtue of the Merger and without any action on the part of the holders, each option to purchase Shares from the Company (\"Company Stock Options,\" and each such option, a \"Company Stock Option\") that had an exercise price per share that is less than $10.047 in cash per share (the \"Cash Amount\") (each, an \"In-the-Money Option\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) that was then outstanding was canceled and, in exchange therefor, the holder of such canceled In-the-Money Option became entitled to receive in consideration of the cancellation of such In-the-Money Option (x) an amount in cash without interest, subject to any applicable tax withholding, equal to the product obtained by multiplying (1) the excess of the Cash Amount over the exercise price per Share underlying such In-the-Money Option by (2) the number of Shares underlying such In-the-Money Option as of immediately prior to the Effective Time and (y) one non-transferable contractual contingent value right for each Share underlying such In-the-Money Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 18, 2025, by and among iTeos Therapeutics, Inc. (the \"Company\"), Concentra Biosciences LLC (\"Parent\"), and Concentra Merger Sub VIII, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Parent completed a tender offer for shares of common stock of the Company (\"Shares\") and thereafter, the Merger Sub merged with and into the Company (the \"Merger\"). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, by virtue of the Merger and without any action on the part of the holders, each option to purchase Shares from the Company (\"Company Stock Options,\" and each such option, a \"Company Stock Option\") that had an exercise price per share that is less than $10.047 in cash per share (the \"Cash Amount\") (each, an \"In-the-Money Option\")"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from footnote 1) that was then outstanding was canceled and, in exchange therefor, the holder of such canceled In-the-Money Option became entitled to receive in consideration of the cancellation of such In-the-Money Option (x) an amount in cash without interest, subject to any applicable tax withholding, equal to the product obtained by multiplying (1) the excess of the Cash Amount over the exercise price per Share underlying such In-the-Money Option by (2) the number of Shares underlying such In-the-Money Option as of immediately prior to the Effective Time and (y) one non-transferable contractual contingent value right for each Share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":6.16,"underlying":"Common Stock","underlying_shares":27178},"source":{"system":"sec-edgar","filing":"0001193125-25-192817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000119312525192817/ownership.xml","form_type":"4"}},{"id":1124498,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2025-06-03T20:08:16.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":325,"derivative":{"underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001906324-25-000135","document":"wk-form4a_1748981286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000135/wk-form4a_1748981286.xml","form_type":"4/A","original_submission_date":"2025-06-02"}},{"id":1124497,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2025-06-03T20:08:16.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Form 4 originally filed on June 2, 2025 is being amended to report the correct vesting dates for the converted restricted stock units granted to the reporting person on May 29, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on February 28, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on February 28, 2026."}],"balance_after":1626,"derivative":{"underlying":"Common Stock","underlying_shares":1626},"source":{"system":"sec-edgar","filing":"0001906324-25-000135","document":"wk-form4a_1748981286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000135/wk-form4a_1748981286.xml","form_type":"4/A","original_submission_date":"2025-06-02"}},{"id":1124496,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-06-03T20:08:16.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."}],"balance_after":6829,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001906324-25-000135","document":"wk-form4a_1748981286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000135/wk-form4a_1748981286.xml","form_type":"4/A","original_submission_date":"2025-06-02"}},{"id":1127372,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2025-06-02T20:11:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":325,"derivative":{"underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001906324-25-000120","document":"wk-form4_1748895057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000120/wk-form4_1748895057.xml","form_type":"4"}},{"id":1127371,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2025-06-02T20:11:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on November 29, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"406 shares vested on May 29, 2025, 406 shares will vest on August 29, 2025, 407 shares will vest on November 29, 2025 and 407 shares will vest on November 29, 2025."}],"balance_after":1626,"derivative":{"underlying":"Common Stock","underlying_shares":1626},"source":{"system":"sec-edgar","filing":"0001906324-25-000120","document":"wk-form4_1748895057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000120/wk-form4_1748895057.xml","form_type":"4"}},{"id":1127370,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-06-02T20:11:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."}],"balance_after":6829,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001906324-25-000120","document":"wk-form4_1748895057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000120/wk-form4_1748895057.xml","form_type":"4"}},{"id":1131658,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2025-05-28T20:19:08.000Z","date":"2025-05-24","kind":"exercise","planned":false,"acquired":false,"shares":109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":109},"source":{"system":"sec-edgar","filing":"0001906324-25-000110","document":"wk-form4_1748463542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000110/wk-form4_1748463542.xml","form_type":"4"}},{"id":1131657,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2025-05-28T20:19:08.000Z","date":"2025-05-24","kind":"exercise","planned":false,"acquired":false,"shares":546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":546},"source":{"system":"sec-edgar","filing":"0001906324-25-000110","document":"wk-form4_1748463542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000110/wk-form4_1748463542.xml","form_type":"4"}},{"id":1131656,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T20:19:08.000Z","date":"2025-05-24","kind":"grant","planned":false,"acquired":true,"shares":109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":14271,"source":{"system":"sec-edgar","filing":"0001906324-25-000110","document":"wk-form4_1748463542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000110/wk-form4_1748463542.xml","form_type":"4"}},{"id":1131655,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T20:19:08.000Z","date":"2025-05-24","kind":"grant","planned":false,"acquired":true,"shares":546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":14162,"source":{"system":"sec-edgar","filing":"0001906324-25-000110","document":"wk-form4_1748463542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000110/wk-form4_1748463542.xml","form_type":"4"}},{"id":1133162,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-05-27T20:26:41.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4929},"source":{"system":"sec-edgar","filing":"0001906324-25-000098","document":"wk-form4_1748377595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000098/wk-form4_1748377595.xml","form_type":"4"}},{"id":1133161,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T20:26:41.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":13616,"source":{"system":"sec-edgar","filing":"0001906324-25-000098","document":"wk-form4_1748377595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000098/wk-form4_1748377595.xml","form_type":"4"}},{"id":1140225,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium )","published_at":"2025-05-20T21:26:06.000Z","date":"2025-05-18","kind":"exercise","planned":false,"acquired":false,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0001906324-25-000077","document":"wk-form4_1747776359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000077/wk-form4_1747776359.xml","form_type":"4"}},{"id":1140224,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2025-05-20T21:26:06.000Z","date":"2025-05-18","kind":"exercise","planned":false,"acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001906324-25-000077","document":"wk-form4_1747776359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000077/wk-form4_1747776359.xml","form_type":"4"}},{"id":1140223,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T21:26:06.000Z","date":"2025-05-18","kind":"grant","planned":false,"acquired":true,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":8687,"source":{"system":"sec-edgar","filing":"0001906324-25-000077","document":"wk-form4_1747776359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000077/wk-form4_1747776359.xml","form_type":"4"}},{"id":1140222,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T21:26:06.000Z","date":"2025-05-18","kind":"grant","planned":false,"acquired":true,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":8559,"source":{"system":"sec-edgar","filing":"0001906324-25-000077","document":"wk-form4_1747776359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000190632425000077/wk-form4_1747776359.xml","form_type":"4"}},{"id":1188732,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-03-28T22:58:03.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 23, 2025, and will vest on January 1, 2026."}],"balance_after":15000,"derivative":{"exercise_price":92.42,"expiration_date":"2035-01-23","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-047031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017025047031/ownership.xml","form_type":"4"}},{"id":1227388,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-04T21:38:25.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":78.68,"value":590100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person."}],"balance_after":35384,"source":{"system":"sec-edgar","filing":"0000950170-25-032220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017025032220/ownership.xml","form_type":"4"}},{"id":1404879,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-09-17T20:34:32.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on January 25, 2016 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":25.52,"expiration_date":"2026-01-25","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-107319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024107319/ownership.xml","form_type":"4"}},{"id":1404878,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-09-17T20:34:32.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 20, 2015 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.1,"expiration_date":"2025-01-20","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-107319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024107319/ownership.xml","form_type":"4"}},{"id":1404877,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:34:32.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":70.36,"value":1055400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.10 to $70.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":42884,"source":{"system":"sec-edgar","filing":"0000950170-24-107319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024107319/ownership.xml","form_type":"4"}},{"id":1404876,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:34:32.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":25.52,"value":510400.0,"ownership":{"direct":true},"balance_after":57884,"source":{"system":"sec-edgar","filing":"0000950170-24-107319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024107319/ownership.xml","form_type":"4"}},{"id":1404875,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:34:32.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":24.1,"value":361500.0,"ownership":{"direct":true},"balance_after":37884,"source":{"system":"sec-edgar","filing":"0000950170-24-107319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024107319/ownership.xml","form_type":"4"}},{"id":1473304,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:35:19.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":3.8,"expiration_date":"2034-06-16","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001415889-24-017659","document":"form4-06202024_040616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000141588924017659/form4-06202024_040616.xml","form_type":"4"}},{"id":1480818,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:00:05.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24200,"derivative":{"exercise_price":16.32,"exercise_date":"2025-06-11","expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":24200},"source":{"system":"sec-edgar","filing":"0000950170-24-073252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000095017024073252/ownership.xml","form_type":"4"}},{"id":1484620,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock (Premium)","published_at":"2024-06-10T20:28:46.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000950170-24-071330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024071330/ownership.xml","form_type":"4"}},{"id":1484619,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2024-06-10T20:28:46.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":1017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1017},"source":{"system":"sec-edgar","filing":"0000950170-24-071330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024071330/ownership.xml","form_type":"4"}},{"id":1484618,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:28:46.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":8132,"source":{"system":"sec-edgar","filing":"0000950170-24-071330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024071330/ownership.xml","form_type":"4"}},{"id":1484617,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:28:46.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":7929,"source":{"system":"sec-edgar","filing":"0000950170-24-071330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024071330/ownership.xml","form_type":"4"}},{"id":1498955,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2024-05-29T20:40:26.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":false,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2416},"source":{"system":"sec-edgar","filing":"0000950170-24-066006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024066006/ownership.xml","form_type":"4"}},{"id":1498954,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:40:26.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":6912,"source":{"system":"sec-edgar","filing":"0000950170-24-066006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024066006/ownership.xml","form_type":"4"}},{"id":1503412,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2024-05-23T22:28:20.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":234,"derivative":{"underlying":"Common Stock","underlying_shares":234},"source":{"system":"sec-edgar","filing":"0000950170-24-064144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024064144/ownership.xml","form_type":"4"}},{"id":1503411,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2024-05-23T22:28:20.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":1173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"293 shares vested on May 22, 2024,  293 shares will vest on August 22, 2024,  293 shares will vest on November 22, 2024 and 294 shares will vest on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"293 shares vested on May 22, 2024,  293 shares will vest on August 22, 2024,  293 shares will vest on November 22, 2024 and 294 shares will vest on February 22, 2025."}],"balance_after":1173,"derivative":{"underlying":"Common Stock","underlying_shares":1173},"source":{"system":"sec-edgar","filing":"0000950170-24-064144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024064144/ownership.xml","form_type":"4"}},{"id":1503410,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2024-05-23T22:28:20.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."}],"balance_after":4929,"derivative":{"underlying":"Common Stock","underlying_shares":4929},"source":{"system":"sec-edgar","filing":"0000950170-24-064144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000095017024064144/ownership.xml","form_type":"4"}},{"id":1666390,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-01-30T21:50:33.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2024, and will vest on January 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-008918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024008918/ownership.xml","form_type":"4"}},{"id":1854543,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T19:56:32.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":22383,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22383,"derivative":{"exercise_price":14.77,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":22383},"source":{"system":"sec-edgar","filing":"0001209191-23-037594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000120919123037594/doc4.xml","form_type":"4"}},{"id":1858939,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:30:55.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":11.66,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001209191-23-036332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919123036332/doc4.xml","form_type":"4"}},{"id":1861951,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-06-08T20:23:08.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":false,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on June 6, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-23-035394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919123035394/doc4.xml","form_type":"4"}},{"id":1861950,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:23:08.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":4496,"source":{"system":"sec-edgar","filing":"0001209191-23-035394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919123035394/doc4.xml","form_type":"4"}},{"id":1877795,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2023-05-26T00:20:30.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":109,"derivative":{"underlying":"Common Stock","underlying_shares":109},"source":{"system":"sec-edgar","filing":"0001209191-23-032329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919123032329/doc4.xml","form_type":"4"}},{"id":1877794,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2023-05-26T00:20:30.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 24, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 24, 2023."}],"balance_after":546,"derivative":{"underlying":"Common Stock","underlying_shares":546},"source":{"system":"sec-edgar","filing":"0001209191-23-032329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919123032329/doc4.xml","form_type":"4"}},{"id":1877793,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-05-26T00:20:30.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."}],"balance_after":2416,"derivative":{"underlying":"Common Stock","underlying_shares":2416},"source":{"system":"sec-edgar","filing":"0001209191-23-032329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919123032329/doc4.xml","form_type":"4"}},{"id":1989956,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-02-27T21:58:45.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":75.18,"expiration_date":"2033-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-013237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123013237/doc4.xml","form_type":"4"}},{"id":2042021,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-01-30T21:37:30.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 30, 2013 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.59,"expiration_date":"2023-01-30","underlying":"Class A Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-23-005487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123005487/doc4.xml","form_type":"4"}},{"id":2042020,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-30T21:37:30.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":7500,"price":12.59,"value":94425.0,"ownership":{"direct":true},"balance_after":22884,"source":{"system":"sec-edgar","filing":"0001209191-23-005487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123005487/doc4.xml","form_type":"4"}},{"id":2236234,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T19:54:54.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":17538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 9, 2023 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":17538,"derivative":{"exercise_price":18.78,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":17538},"source":{"system":"sec-edgar","filing":"0001209191-22-036140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000120919122036140/doc4.xml","form_type":"4"}},{"id":2238847,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2022-06-08T22:19:51.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":203,"derivative":{"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0001209191-22-035178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919122035178/doc4.xml","form_type":"4"}},{"id":2238846,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2022-06-08T22:19:51.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":1017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest on the date of the grant, June 6, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest on the date of the grant, June 6, 2022."}],"balance_after":1017,"derivative":{"underlying":"Common Stock","underlying_shares":1017},"source":{"system":"sec-edgar","filing":"0001209191-22-035178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919122035178/doc4.xml","form_type":"4"}},{"id":2238845,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2022-06-08T22:19:51.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."}],"balance_after":2248,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-22-035178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000120919122035178/doc4.xml","form_type":"4"}},{"id":2249249,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:39:39.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":128,"derivative":{"underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0000899243-22-020501","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000089924322020501/doc4.xml","form_type":"4"}},{"id":2249248,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:39:39.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":427,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0000899243-22-020501","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000089924322020501/doc4.xml","form_type":"4"}},{"id":2249247,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T21:39:39.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":2248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."}],"balance_after":2248,"source":{"system":"sec-edgar","filing":"0000899243-22-020501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250252/000089924322020501/doc4.xml","form_type":"4"}},{"id":2250493,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:26:49.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0000899243-22-020409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020409/doc4.xml","form_type":"4"}},{"id":2250492,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:26:49.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0000899243-22-020409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020409/doc4.xml","form_type":"4"}},{"id":2250491,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:26:49.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":2248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-020409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020409/doc4.xml","form_type":"4"}},{"id":2262733,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2022-05-20T19:48:15.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-18","expiration_date":"2022-05-18","underlying":"Common Stock","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0001209191-22-031191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919122031191/doc4.xml","form_type":"4"}},{"id":2262732,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T19:48:15.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on Form 4."}],"balance_after":2248,"source":{"system":"sec-edgar","filing":"0001209191-22-031191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919122031191/doc4.xml","form_type":"4"}},{"id":2270464,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T23:29:00.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":49000,"derivative":{"exercise_price":9.55,"expiration_date":"2032-05-13","underlying":"Common Shares","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001209191-22-029369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919122029369/doc4.xml","form_type":"4"}},{"id":2420969,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-01-31T21:58:50.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on\nJanuary 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly\nbasis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":63.68,"expiration_date":"2032-01-27","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-005612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122005612/doc4.xml","form_type":"4"}},{"id":2625819,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-23T18:26:11.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":61750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date."}],"balance_after":61750,"derivative":{"exercise_price":1.55,"expiration_date":"2031-05-04","underlying":"Common Stock","underlying_shares":61750},"source":{"system":"sec-edgar","filing":"0001209191-21-048027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919121048027/doc4.xml","form_type":"4"}},{"id":2661412,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:17:14.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":16608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":16608,"derivative":{"exercise_price":26.03,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":16608},"source":{"system":"sec-edgar","filing":"0000899243-21-025130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924321025130/doc4.xml","form_type":"4"}},{"id":2704323,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2021-05-20T20:38:00.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related\nfees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred,\nin which case, payment will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 18, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related\nfees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred,\nin which case, payment will occur according to the elected deferral schedule."}],"balance_after":128,"derivative":{"underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0001209191-21-034707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919121034707/doc4.xml","form_type":"4"}},{"id":2704322,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2021-05-20T20:38:00.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related\nfees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred,\nin which case, payment will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related\nfees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred,\nin which case, payment will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 18, 2021."}],"balance_after":427,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001209191-21-034707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919121034707/doc4.xml","form_type":"4"}},{"id":2704321,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2021-05-20T20:38:00.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 18, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 18, 2022."}],"balance_after":1624,"derivative":{"underlying":"Common Stock","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0001209191-21-034707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919121034707/doc4.xml","form_type":"4"}},{"id":2712535,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T20:52:13.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":21000,"derivative":{"exercise_price":32.44,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-21-032778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919121032778/doc4.xml","form_type":"4"}},{"id":2713556,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-14T20:10:50.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"exercise_date":"2021-05-12","expiration_date":"2021-05-12","underlying":"Common Stock","underlying_shares":624},"source":{"system":"sec-edgar","filing":"0001209191-21-032976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919121032976/doc4.xml","form_type":"4"}},{"id":2713555,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T20:10:50.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on Form 4."}],"balance_after":624,"source":{"system":"sec-edgar","filing":"0001209191-21-032976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919121032976/doc4.xml","form_type":"4"}},{"id":2812345,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2021-03-03T21:32:43.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":15384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on July 28, 2011 and are fully vested."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Initially the stock option provided a right to buy the Company's Class C Common Stock. Upon the closing of the Company's initial public offering, all shares of the Company's Class C Common Stock automatically converted into shares of the Company's Class A Common Stock on a one-for-one basis. As a result, this stock option automatically converted into a right to buy the Company's Class A Common Stock."}],"balance_after":0,"derivative":{"exercise_price":10.66,"expiration_date":"2021-07-28","underlying":"Class A Common Stock","underlying_shares":15384},"source":{"system":"sec-edgar","filing":"0001209191-21-016873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121016873/doc4.xml","form_type":"4"}},{"id":2812344,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-03-03T21:32:43.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":15384,"price":10.66,"value":163993.44,"ownership":{"direct":true},"balance_after":15384,"source":{"system":"sec-edgar","filing":"0001209191-21-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121016873/doc4.xml","form_type":"4"}},{"id":2904094,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2021-01-19T22:02:24.000Z","date":"2021-01-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":65.05,"expiration_date":"2031-01-14","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-004053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121004053/doc4.xml","form_type":"4"}},{"id":3002276,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:55:06.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":16608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This amendment is being filed solely for the purpose of correcting the vesting schedule, as follows: this stock option shall vest on the earlier of (i) the first anniversary of the grant date or (ii) the Company's next annual meeting of stockholders following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":19,"expiration_date":"2030-07-23","underlying":"Common Stock","underlying_shares":16608},"source":{"system":"sec-edgar","filing":"0000899243-20-028901","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924320028901/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-24"}},{"id":3047063,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock  Units","published_at":"2020-08-26T20:27:28.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."}],"balance_after":624,"derivative":{"exercise_date":"2021-05-12","expiration_date":"2021-05-12","underlying":"Common Stock","underlying_shares":624},"source":{"system":"sec-edgar","filing":"0001209191-20-048469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919120048469/doc4.xml","form_type":"4"}},{"id":3076293,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-24T19:19:45.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":16608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest over 3 years, with 1/3 vesting on July 23, 2021 and thereafter in equal monthly installments over the next 24 months subject to the Reporting Person's continued service to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":19,"expiration_date":"2030-07-23","underlying":"Common Stock","underlying_shares":16608},"source":{"system":"sec-edgar","filing":"0000899243-20-020436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924320020436/doc4.xml","form_type":"4"}},{"id":3099917,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-06-25T21:55:51.000Z","date":"2020-06-23","kind":"purchase","acquired":true,"shares":4000,"price":20,"value":80000.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-20-038970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919120038970/doc4.xml","form_type":"4"}},{"id":3104463,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-19T12:06:50.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":38907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Thirty-three percent (33%) of the shares subject to the option shall vest on June 18, 2021, and one twenty-forth (1/24th) of the remaining shares\nsubject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such\ndate."}],"balance_after":38907,"derivative":{"exercise_price":20,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":38907},"source":{"system":"sec-edgar","filing":"0001209191-20-037781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919120037781/doc4.xml","form_type":"4"}},{"id":3130442,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-29T16:48:44.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":61750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date."}],"balance_after":61750,"derivative":{"exercise_price":2.6,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":61750},"source":{"system":"sec-edgar","filing":"0001209191-20-032971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120032971/doc4.xml","form_type":"4"}},{"id":3180677,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:14:02.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":107827,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,442,663.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,442,663.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":107827},"source":{"system":"sec-edgar","filing":"0001209191-20-023713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023713/doc4.xml","form_type":"4"}},{"id":3180676,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:14:02.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":74838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,491,635.22, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,491,635.22, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-26","underlying":"Common Stock","underlying_shares":74838},"source":{"system":"sec-edgar","filing":"0001209191-20-023713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023713/doc4.xml","form_type":"4"}},{"id":3180675,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:14:02.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":120147,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting over a four-year period as follows: (i) 26,710 shares subject to the option vested on March 29, 2019, and (ii) the balance of the shares subject to the option vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $10,412,851.15, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting over a four-year period as follows: (i) 26,710 shares subject to the option vested on March 29, 2019, and (ii) the balance of the shares subject to the option vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $10,412,851.15, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-11","underlying":"Common Stock","underlying_shares":120147},"source":{"system":"sec-edgar","filing":"0001209191-20-023713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023713/doc4.xml","form_type":"4"}},{"id":3180674,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-07T12:14:02.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":37414,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-023713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023713/doc4.xml","form_type":"4"}},{"id":3183393,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:51:55.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":20950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 26,710 shares vested on March 29, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments beginning March 29, 2019, subject to Reporting Person's continuous service as of each such date."}],"balance_after":120147,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-11","underlying":"Common Stock","underlying_shares":20950},"source":{"system":"sec-edgar","filing":"0001209191-20-023388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023388/doc4.xml","form_type":"4"}},{"id":3183392,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":34772,"kind":"person","name":"RHOADS ANN D","position":1,"cik":"0001250252","reported_name":"RHOADS ANN D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:51:55.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":1924,"price":95.425,"value":183597.7,"ownership":{"direct":true},"balance_after":37414,"source":{"system":"sec-edgar","filing":"0001209191-20-023388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023388/doc4.xml","form_type":"4"}}],"next_cursor":"2020-04-03T17:51:55.000000Z,3183392"}